Cite
HARVARD Citation
Haddad, N. et al. (2021). Clinical response to immune checkpoint inhibition in patients with advanced skin cancers receiving concurrent ruxolitinib therapy for haematological malignancy. British journal of dermatology. pp. 564-566. [Online].